Allurion Technologies, Inc. Interest Expense Nonoperating
Allurion Technologies, Inc. (ALUR) reported Interest Expense Nonoperating of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-03-30
- Allurion Technologies, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $0.00.
- Allurion Technologies, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $0.00.
- Allurion Technologies, Inc. interest expense nonoperating for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Allurion Technologies, Inc. interest expense nonoperating for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Allurion Technologies, Inc. interest expense nonoperating for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Allurion Technologies, Inc. interest expense nonoperating for fiscal 2024 was $2.26M, a 78.57% decline from fiscal 2023.
- Allurion Technologies, Inc. interest expense nonoperating for fiscal 2023 was $10.57M, a 138.73% increase from fiscal 2022.
- Allurion Technologies, Inc. interest expense nonoperating for fiscal 2022 was $4.43M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-17 | $0.00 derived: sum of 2 quarters · filed 2025-11-17 | $0.00 10-Q · filed 2025-11-17 | $0.00 derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-19 | $0.00 10-Q · filed 2025-08-19 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | $0.00 derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | $339.00K derived: sum of 4 quarters · filed 2026-03-30 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $339.00K derived: sum of 3 quarters · filed 2026-03-30 | $2.26M 10-K · filed 2026-03-30 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-17 | $339.00K derived: sum of 2 quarters · filed 2025-11-17 | $2.26M 10-Q · filed 2025-11-17 | $5.50M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $339.00K 10-Q/A · filed 2025-08-28 | $2.27M 10-Q/A · filed 2025-08-28 | $5.50M derived: sum of 3 quarters · filed 2025-08-28 | $8.09M derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | $1.93M 10-Q/A · filed 2025-08-28 | $5.17M derived: sum of 2 quarters · filed 2025-08-28 | $7.75M derived: sum of 3 quarters · filed 2025-08-28 | $10.26M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-12-31 | $3.23M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | $5.82M derived: sum of 2 quarters · filed 2025-08-28 | $8.33M derived: sum of 3 quarters · filed 2025-08-28 | $10.57M 10-K/A · filed 2025-08-28 |
| 2023-09-30 | $2.59M 10-Q/A · filed 2025-08-28 | $5.09M derived: sum of 2 quarters · filed 2025-08-28 | $7.33M 10-Q/A · filed 2025-08-28 | |
| 2023-06-30 | $2.51M 10-Q/A · filed 2025-08-28 | $4.75M 10-Q/A · filed 2025-08-28 | ||
| 2023-03-31 | $2.24M 10-Q/A · filed 2025-08-28 | |||
| 2022-12-31 | $4.43M 10-K/A · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |